|
|
Volumn 11, Issue 7, 2014, Pages 366-
|
|
Prostate cancer: Metformin - The new wonder drug?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METFORMIN;
ANTINEOPLASTIC AGENT;
ANTIPROLIFERATIVE ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RISK;
CHEMOPROPHYLAXIS;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG SAFETY;
HUMAN;
MALE;
NOTE;
PRIORITY JOURNAL;
PROSTATE CANCER;
EVIDENCE BASED MEDICINE;
PROSTATIC NEOPLASMS;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
EVIDENCE-BASED MEDICINE;
HUMANS;
MALE;
METFORMIN;
PROSTATIC NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 84904053879
PISSN: 17594812
EISSN: 17594820
Source Type: Journal
DOI: 10.1038/nrurol.2014.136 Document Type: Note |
|
Times cited : (5)
|
|
References (1)
|
